Tobias Gold

This study identifies novel Leishmania virulence factors through proteomics of infected macrophages and presents a database for further research.

Oral L-arginine therapy prevents and cures arginase 1-dependent chronic cutaneous leishmaniasis by restoring arginine levels and shifting the T helper cell response.

This study shows that eosinophils contribute to chronic cutaneous leishmaniasis by expressing a unique metabolic profile that suppresses Th1 responses.